Remove Bioinformatics Remove Therapies Remove Treatment Remove Workshop
article thumbnail

Looking ahead to AACR  

Drug Discovery World

Programme highlights The topic tracks include everything from clinical trials, drug development, immunology and bioinformatics, to global health, survivorship, prevention and tumour biology, to name just a few. The workshop will be led by hfp consulting, a firm which specialises in career development and leadership training for scientists.

article thumbnail

Article FDA Thank You Leaders at FDA share highlights and updates for drugs and biologics at RAPS Convergence

Agency IQ

Joneckis said that CBER has “some limited uses that we have seen in external submissions, mostly in the bioinformatics area,” but not as many as CDER. Marks also offered thoughts on the “critical juncture” for gene therapies. With 15 gene therapies now approved in the U.S.,

FDA 40
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

Developing therapeutic antibodies, one of the most successful approaches in drug development, involves identifying and characterising antibodies to be used as treatment against different types of cancers as well as autoimmune and cardiovascular diseases. Synthetic libraries for antibody drug discovery .

DNA 246